Healthcare provider profile · identity verified

Bernadeth Angella Alcott, NP

Nurse Practitioner · HEMPSTEAD, NY · NPI 1699097733

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	253	117
Amlodipine Besylate	Amlodipine Besylate	182	75
Metformin Hcl	Metformin Hcl	166	69
Albuterol Sulfate Hfa	Albuterol Sulfate	149	54
Fluticasone Propionate	Fluticasone Propionate	129	57
Levothyroxine Sodium	Levothyroxine Sodium	115	46
Lisinopril	Lisinopril	115	49
Hydrochlorothiazide	Hydrochlorothiazide	112	44
Gabapentin	Gabapentin	110	60
Losartan Potassium	Losartan Potassium	101	46
Famotidine	Famotidine	99	36
Diclofenac Sodium	Diclofenac Sodium	96	39
Omeprazole	Omeprazole	93	42
Simvastatin	Simvastatin	91	39
Alendronate Sodium	Alendronate Sodium	83	33
Metoprolol Succinate	Metoprolol Succinate	75	30
Glipizide	Glipizide	74	23
Ammonium Lactate	Ammonium Lactate	68	26
Allopurinol	Allopurinol	58	21
Januvia	Sitagliptin Phosphate	52	19
Tamsulosin Hcl	Tamsulosin Hcl	48	20
Meloxicam	Meloxicam	46	19
Fenofibrate	Fenofibrate,micronized	45	18
Jardiance	Empagliflozin	43	17
Atenolol	Atenolol	35	16
Vascepa	Icosapent Ethyl	35	11
Enalapril Maleate	Enalapril Maleate	34	12
Metoprolol Tartrate	Metoprolol Tartrate	34	18
Alcohol Prep Pads	Alcohol Antiseptic Pads	33	suppressed
Ibuprofen	Ibuprofen	33	16
Meclizine Hcl	Meclizine Hcl	32	21
Pioglitazone Hcl	Pioglitazone Hcl	32	11
Rosuvastatin Calcium	Rosuvastatin Calcium	32	16
Tizanidine Hcl	Tizanidine Hcl	30	16
Triamcinolone Acetonide	Triamcinolone Acetonide	30	14
Clopidogrel	Clopidogrel Bisulfate	29	13
Nifedipine Er	Nifedipine	27	suppressed
Tradjenta	Linagliptin	27	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Ozempic	Semaglutide	26	suppressed
Carvedilol	Carvedilol	25	12
Furosemide	Furosemide	24	15
Glimepiride	Glimepiride	24	11
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Hydrocortisone	Hydrocortisone	23	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	23	14
Donepezil Hcl	Donepezil Hcl	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Montelukast Sodium	Montelukast Sodium	19	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	17	15
Naproxen	Naproxen	17	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	16	suppressed
Nystatin	Nystatin	16	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Fosinopril Sodium	Fosinopril Sodium	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Single Use Swab	Alcohol Antiseptic Pads	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Clonidine	Clonidine	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Edarbi	Azilsartan Medoxomil	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Finasteride	Finasteride	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error